Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors

Zurück zum Zitat Labastie MC, Bories D, Chabret C, Gregoire JM, Chretien S, Romeo PH (1994) Structure and expression of the human GATA3 gene. Genomics 21(1):1–6. doi:10.1006/geno.1994.1217 CrossRefPubMed Labastie MC, Bories D, Chabret C, Gregoire JM, Chretien S, Romeo PH (1994) Structure and expression of the human GATA3 gene. Genomics 21(1):1–6. doi:10.​1006/​geno.​1994.​1217 CrossRefPubMed

Zurück zum Zitat Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, Yamamoto M, Engel JD (1994) Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14(3):2201–2212PubMed Yang Z, Gu L, Romeo PH, Bories D, Motohashi H, Yamamoto M, Engel JD (1994) Human GATA-3 trans-activation, DNA-binding, and nuclear localization activities are organized into distinct structural domains. Mol Cell Biol 14(3):2201–2212PubMed

Zurück zum Zitat Simon MC (1995) Gotta have GATA. Nat Genet 11(1):9–11. doi:10.1038/ng0995-9 CrossRefPubMed Simon MC (1995) Gotta have GATA. Nat Genet 11(1):9–11. doi:10.​1038/​ng0995-9 CrossRefPubMed

Zurück zum Zitat Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11(1):40–44. doi:10.1038/ng0995-40 CrossRefPubMed Pandolfi PP, Roth ME, Karis A, Leonard MW, Dzierzak E, Grosveld FG, Engel JD, Lindenbaum MH (1995) Targeted disruption of the GATA3 gene causes severe abnormalities in the nervous system and in fetal liver haematopoiesis. Nat Genet 11(1):40–44. doi:10.​1038/​ng0995-40 CrossRefPubMed

Zurück zum Zitat Karis A, Pata I, van Doorninck JH, Grosveld F, de Zeeuw CI, de Caprona D, Fritzsch B (2001) Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear. J Comp Neurol 429(4):615–630. 10.1002/1096-9861(20010122)429:4<;615::AID-CNE8>;3.0.CO;2-Fdoi: Karis A, Pata I, van Doorninck JH, Grosveld F, de Zeeuw CI, de Caprona D, Fritzsch B (2001) Transcription factor GATA-3 alters pathway selection of olivocochlear neurons and affects morphogenesis of the ear. J Comp Neurol 429(4):615–630. 10.​1002/​1096-9861(20010122)429:​4<;615:​:​AID-CNE8>;3.​0.​CO;2-Fdoi:

Zurück zum Zitat Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J et al (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9(2):201–209. doi:10.1038/ncb1530 CrossRefPubMed Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J et al (2007) Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 9(2):201–209. doi:10.​1038/​ncb1530 CrossRefPubMed

Zurück zum Zitat Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127(5):1041–1055. doi:10.1016/j.cell.2006.09.048 CrossRefPubMed Kouros-Mehr H, Slorach EM, Sternlicht MD, Werb Z (2006) GATA-3 maintains the differentiation of the luminal cell fate in the mammary gland. Cell 127(5):1041–1055. doi:10.​1016/​j.​cell.​2006.​09.​048 CrossRefPubMed

Zurück zum Zitat Tlsty TD (2007) Luminal cells GATA have it. Nat Cell Biol 9(2):135–136. doi:10.1038/ncb0207-135 CrossRefPubMed Tlsty TD (2007) Luminal cells GATA have it. Nat Cell Biol 9(2):135–136. doi:10.​1038/​ncb0207-135 CrossRefPubMed

Zurück zum Zitat Tong Q, Hotamisligil GS (2007) Developmental biology: cell fate in the mammary gland. Nature 445(7129):724–726. doi:10.1038/445724a CrossRefPubMed Tong Q, Hotamisligil GS (2007) Developmental biology: cell fate in the mammary gland. Nature 445(7129):724–726. doi:10.​1038/​445724a CrossRefPubMed

Zurück zum Zitat Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi:10.1073/pnas.191367098 CrossRefPubMed Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98(19):10869–10874. doi:10.​1073/​pnas.​191367098 CrossRefPubMed

Zurück zum Zitat Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14):8418–8423. doi:10.1073/pnas.0932692100 CrossRefPubMed Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, Deng S, Johnsen H, Pesich R, Geisler S et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100(14):8418–8423. doi:10.​1073/​pnas.​0932692100 CrossRefPubMed

Zurück zum Zitat Voduc D, Cheang M, Nielsen T (2008) GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17(2):365–373. doi:10.1158/1055-9965.EPI-06-1090 CrossRefPubMed Voduc D, Cheang M, Nielsen T (2008) GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value. Cancer Epidemiol Biomarkers Prev 17(2):365–373. doi:10.​1158/​1055-9965.​EPI-06-1090 CrossRefPubMed

Zurück zum Zitat Garcia-Closas M, Troester MA, Qi Y, Langerod A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS et al (2007) Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev 16(11):2269–2275. doi:10.1158/1055-9965.EPI-07-0449 CrossRefPubMed Garcia-Closas M, Troester MA, Qi Y, Langerod A, Yeager M, Lissowska J, Brinton L, Welch R, Peplonska B, Gerhard DS et al (2007) Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status. Cancer Epidemiol Biomarkers Prev 16(11):2269–2275. doi:10.​1158/​1055-9965.​EPI-07-0449 CrossRefPubMed

Zurück zum Zitat Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X (2008) kConFab Investigators, AOCS Group, The Swedish BRCA1 and BRCA2 Study Collaborators, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek S.M, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko Y-D, Heikkinen T, Aaltonen K, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu J, Peock S, Cook M, Platte R, Evans D.G, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FBL, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TAM, Gille HJP, Blok MJ, HEBON Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Georgia Chenevix-Trench, Breast Cancer Association Consortium, Consortium of Investigators of Modifiers of BRCA1/2: No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Res Treat. doi:10.1007/s10549-008-0257-1 Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen X (2008) kConFab Investigators, AOCS Group, The Swedish BRCA1 and BRCA2 Study Collaborators^, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek S.M, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko Y-D, Heikkinen T, Aaltonen K, Aittomäki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu J, Peock S, Cook M, Platte R, Evans D.G, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FBL, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TAM, Gille HJP, Blok MJ, HEBON Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Georgia Chenevix-Trench, Breast Cancer Association Consortium, Consortium of Investigators of Modifiers of BRCA1/2: No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Res Treat. doi:10.​1007/​s10549-008-0257-1

Zurück zum Zitat Chanock SJ, Burdett L, Yeager M, Llaca V, Langerod A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V et al (2007) Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res 9(1):R5. doi:10.1186/bcr1637 CrossRefPubMed Chanock SJ, Burdett L, Yeager M, Llaca V, Langerod A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V et al (2007) Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas. Breast Cancer Res 9(1):R5. doi:10.​1186/​bcr1637 CrossRefPubMed

Zurück zum Zitat Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerod A, Karesen R, Oh DS, Dressler LG et al (2004) Mutation of GATA3 in human breast tumors. Oncogene 23(46):7669–7678. doi:10.1038/sj.onc.1207966 CrossRefPubMed Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerod A, Karesen R, Oh DS, Dressler LG et al (2004) Mutation of GATA3 in human breast tumors. Oncogene 23(46):7669–7678. doi:10.​1038/​sj.​onc.​1207966 CrossRefPubMed

Zurück zum Zitat Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12. doi:10.1186/bcr1377 CrossRefPubMed Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E, Evans GM, Fereday S, Haan E, Gattas M et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8(1):R12. doi:10.​1186/​bcr1377 CrossRefPubMed

Zurück zum Zitat Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. doi:10.1093/nar/16.3.1215 CrossRefPubMed Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215. doi:10.​1093/​nar/​16.​3.​1215 CrossRefPubMed

Zurück zum Zitat Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51(13):3497–3502PubMed Levi S, Urbano-Ispizua A, Gill R, Thomas DM, Gilbertson J, Foster C, Marshall CJ (1991) Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 51(13):3497–3502PubMed

Zurück zum Zitat Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093. doi:10.1038/nature05887 CrossRefPubMed Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG, Struewing JP, Morrison J, Field H, Luben R et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447(7148):1087–1093. doi:10.​1038/​nature05887 CrossRefPubMed

Zurück zum Zitat Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA et al (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94(3):205–215PubMed Chenevix-Trench G, Spurdle AB, Gatei M, Kelly H, Marsh A, Chen X, Donn K, Cummings M, Nyholt D, Jenkins MA et al (2002) Dominant negative ATM mutations in breast cancer families. J Natl Cancer Inst 94(3):205–215PubMed

Zurück zum Zitat Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875. doi:10.1038/ng1837 CrossRefPubMed Renwick A, Thompson D, Seal S, Kelly P, Chagtai T, Ahmed M, North B, Jayatilake H, Barfoot R, Spanova K et al (2006) ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. Nat Genet 38(8):873–875. doi:10.​1038/​ng1837 CrossRefPubMed

Zurück zum Zitat Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K et al (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239–1241. doi:10.1038/ng1902 CrossRefPubMed Seal S, Thompson D, Renwick A, Elliott A, Kelly P, Barfoot R, Chagtai T, Jayatilake H, Ahmed M, Spanova K et al (2006) Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles. Nat Genet 38(11):1239–1241. doi:10.​1038/​ng1902 CrossRefPubMed

Zurück zum Zitat Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167. doi:10.1038/ng1959 CrossRefPubMed Rahman N, Seal S, Thompson D, Kelly P, Renwick A, Elliott A, Reid S, Spanova K, Barfoot R, Chagtai T et al (2007) PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene. Nat Genet 39(2):165–167. doi:10.​1038/​ng1959 CrossRefPubMed